JBS3 Guidelines50
Stanols and sterols appear to offer a degree of LDL-cholesterol reduction (approximately 10%) even with concomitant statin use. Although there is no CVD outcome data for such products (and never likely to be), it is reasonable to assume a beneficial effect on CVD outcomes based on the LDL lowering hypothesis.